Safety and Pharmacokinetics of Intravitreal 2-Methoxyestradiol Implants in Normal Rabbit and Pharmacodynamics in a Rat Model of Choroidal Neovascularization
- 28 February 2002
- journal article
- research article
- Published by Elsevier in Experimental Eye Research
- Vol. 74 (2) , 309-317
- https://doi.org/10.1006/exer.2001.1132
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Development of new drug delivery system for protein drugs using silicone (I)Journal of Controlled Release, 2000
- Age-Related Macular DegenerationNew England Journal of Medicine, 2000
- Formulation Development and Antitumor Activity of a Filter-Sterilizable Emulsion of PaclitaxelPharmaceutical Research, 2000
- Glucocorticoids alter recovery processes in the rat retinaNeuroReport, 1998
- 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site.Proceedings of the National Academy of Sciences, 1994
- The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growthNature, 1994
- Age-related Macular Degeneration Histopathologic StudiesOphthalmology, 1993
- Natural Course of Poorly Defined Choroidal Neovascularization Associated With Macular DegenerationArchives of Ophthalmology (1950), 1988
- Retinal Pigment Epithelial Cells Release inhibitors of NeovascularizationOphthalmology, 1987
- Age-Related Macular Degeneration and Blindness due to Neovascular MaculopathyArchives of Ophthalmology (1950), 1984